Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer
about
Cost-effectiveness Analysis of Nivolumab for Treatment of Platinum-Resistant Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck.The cost-effectiveness of oral health interventions: A systematic review of cost-utility analyses.Positive Surgical Margins in the 10 Most Common Solid Cancers.
P2860
Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Cost-Effectiveness Analysis of ...... de-Negative Oral Cavity Cancer
@ast
Cost-Effectiveness Analysis of ...... de-Negative Oral Cavity Cancer
@en
type
label
Cost-Effectiveness Analysis of ...... de-Negative Oral Cavity Cancer
@ast
Cost-Effectiveness Analysis of ...... de-Negative Oral Cavity Cancer
@en
prefLabel
Cost-Effectiveness Analysis of ...... de-Negative Oral Cavity Cancer
@ast
Cost-Effectiveness Analysis of ...... de-Negative Oral Cavity Cancer
@en
P2093
P2860
P356
P1476
Cost-Effectiveness Analysis of ...... de-Negative Oral Cavity Cancer
@en
P2093
Assuntina G Sacco
Bayard Wilson
Charles S Coffey
James D Murphy
Joseph R Acevedo
Katherine E Fero
Loren K Mell
P2860
P356
10.1200/JCO.2016.68.4563
P407
P577
2016-08-22T00:00:00Z